A mixed Th1/Th2 cell cytokine response predominates in systemic onset juvenile rheumatoid arthritis: Immunoregulatory IL-10 function

Clinical Immunology and Immunopathology

Volumn 86, Issue 2, 1998, Pages 192-198

  Raziuddin, Syed ^a   Bahabri, Sultan ^a   Al Dalaan, Abdullah ^a   Siraj, A K ^a   Al Sedairy, Sultan ^a  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

Author keywords

CD28 CD3; Interleukin 10; Interleukin 4; Juvenile rheumatoid arthritis; Th1 Th2 cells

Indexed keywords

CD28 ANTIGEN; CD3 ANTIGEN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6;

ARTICLE; CHILD; CLINICAL ARTICLE; FEMALE; HELPER CELL; HUMAN; HUMAN CELL; JUVENILE RHEUMATOID ARTHRITIS; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL;

EID: 0032007026     PISSN: 00901229     EISSN: None     Source Type: Journal    
DOI: 10.1006/clin.1997.4457     Document Type: Article

References (41)

1. Carter L. L., Dutton R. W. Type 1 and type 2: A fundamental dichotomy for all T cell subsets. Curr. Opin. Immunol. 9:1996;336-342.
2. Mossman T. R., Coffman R. L. Th1 and Th2 cells: Different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7:1989;145-173.
3. Romognani S. Lymphokine production by human T cells in disease states. Annu. Rev. Immunol. 12:1994;227-257.
4. Duff G. W. Cytokines and anti-cytokines. Br. J. Rheumatol. 1:1993;15-20.
5. Charlton B., Lafferty K. J. The Th1/Th2 balance in autoimmunity. Curr. Opin. Immunol. 7:1995;793-798.
6. Cassidy J. T., Petty R. E. Textbook of Pediatric Rheumatology. 1990;Churchill Livingstone, New York.
7. Wood P. H. N. Special meeting on nomenclature and classification of arthritis in children. The Care of Rheumatic Children. 1987;EULAR Pub. Basel. p. 47-50.
8. Mangge H., Kenzian H., Gullish S., Neuwrith G., Liebmann P., Kaufersch W., Beaufort F., Muntean W., Schauenstein K. Serum cytokines in juvenile rheumatoid arthritis: Correlation with conventional inflammation parameters and subtypes. Arthritis Rheum. 38:1995;211-220.
9. Benedetti F. D., Massa M., Pignatti P., Kelley M., Faltynek C., Martini A. Elevated circulating interleukin-7 levels in patients with systemic juvenile rheumatoid arthritis. J. Rheumatol. 22:1995;1581-1585.
10. Oen K., Danell G. Interleukin-6 and autoantibodies in juvenile rheumatoid arthritis. J. Rheumatol. 20:1993;1949-1956.
11. Lepore L., Pennesi M., Saletta S., Perticarari S., Presani G., Prodan M. Study of IL-2, IL-6, TNFa, IFN-g, and b in the serum and synovial fluid of patients with juvenile chronic arthritis. Clin. Exp. Rheumatol. 12:1994;561-565.
12. Massa M., Benedetti F. D., Robbioni P., Ramenghi B., Albani S., Martini A. Association of methotrexate treatment with a decrease of double negative (CD-4CD-8) and g/d T cell levels in patients with rheumatoid arthritis. J. Rheumatol. 20:1993;1944-1948.
13. de Graeff-Meeder E., Van Eden W., Rijkers G., Prakken B., Kuis W., Voorhorst-Ognik M., Vander Zee R., Schurman H. J., Helders P. J., Zegers B. J. Juvenile chronic arthritis: T cell reactivity to human HSP60 in patients with a favorable course of arthritis. J. Clin. Invest. 95:1995;934-940.
14. Rooney M., David J., Symons J., Di Giovine F., Varsani H., Woo P. Inflammatory cytokine response in juvenile chronic arthritis. Br. J. Rheumatol. 34:1995;454-460.
15. Brewer E. J. Jr., Bass J., Baum J., Cassidy J. T., Flink C., Jacobs J., Hanson V., Levinson J. E., Schaller J., Stillman J. S. Current proposed revision of JRA criteria. Arthritis Rheum. 20:1977;195-199.
16. Bahabri S., Sewairi W., Al-Mazyad A., Karrar A., Al-Ballaa S., El-Ramahai K., Al-Dalaan A. Juvenile rheumatoid arthritis: Saudi experience. Clin. Exp. Rheumatol. 11:1993.
17. Arnett F. C., Edworthy S. M., Bloch D. A., McShane D. J., Fries J. F., Cooper N. S., Healey L. A., Kaplan S. R., Liang M. H., Luthra H. S., Medsger T. A., Mitchell D. M., Neustadt D. H., Pinal S. R. S., Schaller J. G., Sharp J. T., Wilder R. L., Hander G. G. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 31:1988;315-324.
18. Wicher J. T., Evans S. W. Cytokines in disease. Clin. Chem. 36:1990;1269-1281.
19. Reiner S. L., Locksley R. M. The regulation of immunity to leishmania major. Annu. Rev. Immunol. 13:1995;151-177.
20. Clerici M., Shearer G. M. The Th1/Th2 hypothesis of HIV infection: New insights. Immunol. Today. 15:1994;575-581.
21. +. J. Clin. Immunol. 15:1995;338-348.
22. Vowel B. R., Cassin M., Vonderheid E. C., Rook A. H. Aberrant cytokine production by sezary syndrome patients: Cytokine secretion pattern resembles murine Th2 cells. J. Invest. Dermatol. 99:1992;90-94.
23. Huang M., Wang J., Lee P., Modlin R., Wollman J., Dubinetti S. Human non-small cell lung cancer cells express a type 2 cytokine pattern. Cancer Res. 55:1995;3847-3853.
24. Simon A. K., Seipet E., Sieper J. Divergent T cell cytokine pattern in inflammatory arthritis. Proc. Natl. Acad. Sci. USA. 91:1994;8562-8566.
25. Cogan E., Schandene L., Crusiaux A., Cochaux P., Velu T., Goldman M. Clonal proliferation of type 2 helper T cells in a man with hypereosinophilic syndrome. N. Engl. J. Med. 330:1994;534-538.
26. Thompson C. B., Linsten T., Ledbetter J. A., Kunkel S. L., Young H. A., Emerson S. G., Leiden J. M., June C. H. CD28 activation pathway regulates the production of multiple T cell derived lymphokines/cytokines. Proc. Natl. Acad. Sci. USA. 86:1989;1333-1339.
27. Corry D. B., Reiner S. L., Linsley P. S., Locksley R. M. Differential blockade of CD28-B7 on the development of Th1 or Th2 effector cells in experimental leishmania. J. Immunol. 153:1994;4142-4147.
28. Webb L., Feldmann M. Critical role of CD28/B7 costimulation in the development of human Th2 cytokine-producing cells. Blood. 9:1995;3479-3486.
29. De Waal Malefyt R., Yssel H., Roncarolo M. G., Spits H., de Vries J. E. Interleukin-10. Curr. Opin. Immunol. 4:1992;314-320.
30. Howard M., O'Garra A. Biological properties of interleukin-10. Immunol. Today. 13:1992;198-200.
31. Howard M., Muchamuel T., Andrade S., Menon S. Interleukin-10 protects mice from lethal endotoxemia. J. Exp. Med. 177:1993;1205-1208.
32. Cohen S., Katsikis P., Chu C., Thomssen H., Webb L., Maini R., Londei M., Feldmann M. High levels of interleukin-10 production by the activated T cell population within the rheumatoid synovial membrane. Arthritis Rheum. 38:1995;946-952.
33. Isomaki P., Luukkainen R., Saario R., Toivanen P., Punaonens J. Interleukin-10 functions as an anti-inflammatory cytokine in rheumatoid arthritis. Arthritis Rheum. 39:1996;386-395.
34. Katsikis P., Chu C., Brennan F., Maini R., Feldmann M. Immunoregulatory role of interleukin-10 in rheumatoid arthritis. J. Exp. Med. 179:1994;1517-1527.
35. Benedetti F., Massa M., Pignatti P., Albani S., Novick D., Martini A. Serum soluble interleukin-6 (IL-6) receptor and IL-6/soluble IL-6 receptor complex in systemic juvenile rheumatoid arthritis. J. Clin. Invest. 93:1994;2114-2119.
36. Van Snick J. Interleukin 6: An overview. Annu. Rev. Immunol. 8:1990;253-278.
37. Hirano T., Akira S., Taga T., Kishimoto T. Biological and clinical aspects of interleukin-6. Immunol. Today. 11:1990;443-449.
38. Cappio F., Bertero M., Conrerso M., Stacchini A., Vinante F., Romagnani S., Pizzolo G. Circulating levels of soluble CD30, a marker of cells producing Th2 type cytokines are increased in patients with systemic lupus erythematosus and correlate with disease activity. Clin. Exp. Rheumatol. 13:1995;339-343.
39. Trembleau S., Penna G., Bosi E., Mortara A., Gately M. K., Adorini L. Interleukin-12 administration induces T helper type 1 cells and accelerates autoimmune diabetes in NOD mice. J. Exp. Med. 181:1995;817-821.
40. Chehimi J., Starr S. E., Frank I., D'Andrea A., Ma X., MacGregor R. R., Sennelier J., Trincheri G. Impaired interleukin-12 production in human immunodeficiency virus infected patients. J. Exp. Med. 179:1994;1361-1366.
41. Barcellini W., Rizzardi G. P., Borghi M. O., Fan C., Lazzan A., Menon P. L. TH1 and TH2 cytokine production by peripheral blood mononuclear cells from HIV infected patients. AIDS. 8:1994;757-762.